Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TRDA Entrada Therapeutics

Watchlist
15.710
+0.260+1.68%
Close  02/07 16:00 ET
15.7100.0000.00%
Post Mkt Price 02/07 16:00 ET
High
15.910
Open
15.290
Turnover
613.47K
Low
15.200
Pre Close
15.450
Volume
39.52K
Market Cap
493.39M
P/E(TTM)
Loss
52wk High
24.380
Shares
31.41M
P/E(Static)
Loss
52wk Low
5.120
Float Cap
169.75M
Bid/Ask %
0.00%
Historical High
36.850
Shs Float
10.81M
Volume Ratio
0.62
Historical Low
5.120
Dividend TTM
--
Div Yield TTM
--
P/B
2.12
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
4.60%
Avg Price
15.522
Lot Size
1
Float Cap
169.75M
Bid/Ask %
0.00%
Historical High
36.850
Shs Float
10.81M
Volume Ratio
0.62
Historical Low
5.120
Dividend TTM
--
P/B
2.12
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
4.60%
Avg Price
15.522
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.
CEO: Mr. Dipal Doshi
Market: NASDAQ
Listing Date: 10/29/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist